EcoR1 Capital LLC 13D and 13G filings for NGM Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 6:12 pm Sale |
2023-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM |
EcoR1 Capital LLC | 2,385,873 2.900% |
-4,049,645 (-62.93%) |
Filing |
| 2022-10-28 5:34 pm Purchase |
2022-10-18 | 13G | NGM Biopharmaceuticals, Inc. NGM |
EcoR1 Capital LLC | 6,435,518 8.000% |
6,435,518 (New Position) |
Filing |